Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
1.
J Dairy Sci ; 105(12): 9792-9798, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36307236

RESUMEN

More and more sensor and automation data are available that enable animal breeders to define novel traits. However, sensor and automation data are often frequently measured differently (e.g., milk yield and different milk components are continuously measured during each milking). These differences are challenging animal breeders to define traits and use the most appropriate analytical models for genetic evaluation and breeding values. Traditionally, the process from raw data to breeding value estimations involves several steps: data curation, trait definition, variance component estimation, genetic evaluation, and validation of the estimated breeding values (EBV). All these steps often take many iterations and several research projects to optimize the final genetic evaluations. To make this entire process-from raw data to validated EBV-more efficient, we combined all these steps in a cloud environment that allows for faster processing and a faster data distribution time. We used real data (including 1,782,373,113 daily milk-yield records of 1,120,550 dairy cows) and a real trait (a resilience trait based on the deviations from expected milk yields) to demonstrate the functioning of this cloud environment. The daily milk-yield records were incorporated into our cloud solution, in which we have set up central binary large object storage. Subsequent steps were all performed in the cloud. The data set was preprocessed in approximately 6 h to obtain the resilience indicator for 352,871 cows in the first 3 lactations. Estimation of genetic parameters (heritabilities and genetic correlations) was performed by splitting the data into 5 subsets in ASReml, and prediction of subsequent EBV was performed on the entire data set using MiXBLUP. Together with the validation of breeding values, this process encompassed 16.5 h. By combining the different steps from preprocessing sensor data to genetic evaluation of new traits in one cloud environment, we generated EBV and validation plots in approximately 1 working day. Moreover, our setup is a flexible design and can be adapted easily to test new, longitudinal sensor-driven traits and compare the performance of these new traits to previous ones.


Asunto(s)
Lactancia , Leche , Femenino , Bovinos/genética , Animales , Lactancia/genética , Fenotipo
2.
J Dairy Sci ; 105(10): 8158-8176, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36028351

RESUMEN

Resilience is the ability of cows to be minimally affected by disturbances, such as pathogens, heat waves, and changes in feed quality, or to quickly recover. Obvious advantages of resilience are good animal welfare and easy and pleasant management for farmers. Furthermore, economic effects are also expected, but these remain to be determined. The goal of this study was to investigate the association between resilience and lifetime gross margin, using indicators of resilience calculated from fluctuations in daily milk yield using an observational study. Resilience indicators and lifetime gross margin were calculated for 1,325 cows from 21 herds. These cows were not alive anymore and, therefore, had complete lifetime data available for many traits. The resilience indicators were the natural log-transformed variance (LnVar) and the lag-1 autocorrelation (rauto) of daily milk yield deviations from cow-specific lactation curves in parity 1. Good resilience is indicated by low LnVar (small yield response to disturbances) and low rauto (quick yield recovery to baseline). Lifetime gross margin was calculated as the sum of all revenues minus the sum of all costs throughout life. Included revenues were from milk, calf value, and slaughter of the cow. Included costs were from feed, rearing, insemination, management around calving, disease treatments, and destruction in case of death on farm. Feed intake was unknown and, therefore, lifetime feed costs had to be estimated based on milk yield records. The association of each resilience indicator with lifetime gross margin, and also with the underlying revenues and costs, was investigated using analysis of covariance (ANCOVA) models. Mean daily milk yield in first lactation, herd, and year of birth were included as covariates and factors. Natural log-transformed variance had a significantly negative association with lifetime gross margin, which means that cows with stable milk yield (low LnVar, good resilience) in parity 1 generated on average a higher lifetime gross margin than cows that had the same milk yield level but with more fluctuations. The association with lifetime gross margin could be mainly attributed to higher lifetime milk revenues for cows with low LnVar, due to a longer lifespan. Unlike LnVar, rauto was not significantly associated with lifetime gross margin or any of the underlying lifetime costs and revenues. However, it was significantly associated with yearly treatment costs, which is important for ease of management. In conclusion, the importance of resilience for total profit generated by a cow at the end of life was confirmed by the significant association of LnVar with lifetime gross margin, although effects of differences in feed efficiency between resilient and less resilient cows remain to be studied. The economic advantage can be mainly ascribed to benefits of long lifespan.


Asunto(s)
Industria Lechera , Leche , Animales , Bovinos , Femenino , Lactancia/fisiología , Longevidad , Paridad , Embarazo
3.
Trials ; 23(1): 596, 2022 Jul 26.
Artículo en Inglés | MEDLINE | ID: mdl-35883143

RESUMEN

BACKGROUND: Large-scale trials of multidomain interventions show that modifying lifestyle and psychological risk factors can slow cognitive decline. We aim to determine if a lower intensity, personally tailored secondary dementia prevention programme for older people with subjective or mild objective memory decline, informed by behaviour change theory, reduces cognitive decline over 2 years. METHODS: A multi-site, single-blind randomised controlled trial recruiting 704 older adults at high dementia risk due to mild cognitive impairment (MCI) or subjective cognitive decline (SCD). Participants are randomised using 1:1 allocation ratio to the APPLE Tree intervention versus control arm (dementia prevention information), stratified by site. The intervention explores and implements strategies to promote healthy lifestyle, increase pleasurable activities and social connections and improve long-term condition self-management. Two facilitators trained and supervised by a clinical psychologist deliver ten, 1-h group video call sessions over 6 months (approximately every fortnight), video-call 'tea breaks' (less structured, facilitated social sessions) in intervening weeks and individual goal-setting phone calls every 2 weeks. From 6 to 12 months, participants meet monthly for 'tea breaks', with those not attending receiving monthly goal-setting phone calls. Participants receive a food delivery, pedometer and website access to cognitive training and information about lifestyle modification. Follow-ups for all outcome measures are at 12 and 24 months. The primary outcome is cognition (Neuropsychological Test Battery (NTB) score) at 24 months. Secondary outcomes are quality of life, cost per quality-adjusted life year (QALY) and wellbeing and lifestyle factors the intervention targets (diet, vascular risk, body weight, activity, sleep, anxiety, depression, social networks and loneliness, alcohol intake and smoking). Participants from purposively selected sites participate in qualitative process evaluation interviews, which will be analysed using thematic analytic methods. DISCUSSION: If effective, the intervention design, involving remote delivery and non-clinical facilitators, would facilitate intervention roll-out to older people with memory concerns. TRIAL REGISTRATION: ISRCTN17325135 . Registration date 27 November 2019.


Asunto(s)
Demencia , Malus , Anciano , Análisis Costo-Beneficio , Humanos , Estilo de Vida , Calidad de Vida , Método Simple Ciego , , Tecnología
4.
J Dairy Sci ; 104(7): 8094-8106, 2021 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-33838884

RESUMEN

Resilient cows are minimally affected in their functioning by disturbances, and if affected, they quickly recover. Previously, the variance and autocorrelation of daily deviations from a lactation curve were proposed as resilience indicators. These traits were heritable and genetically associated with good health and longevity. However, it was unknown if selection for these indicators would lead to desired changes in the phenotype. The first aim of this study was to investigate if forward prediction of the resilience indicators in another environment was possible. Therefore, the resilience indicator records were split into 2 subsets, each containing half of the daughters of each sire, split within sire into cows that calved in early year-seasons and cows that calved in more recent year-seasons. Genetic correlations between the subsets were then estimated for each resilience indicator. The second aim was to estimate genetic correlations between the resilience indicators and traits describing production responses to actual disturbances. The disturbances were a heat wave in July 2015 and yield disturbances at herd level. The latter were selected by decreases in mean yield of all primiparous cows in a herd, indicating that a disturbance occurred. The data set used for calculation of the resilience indicators and the traits describing yield responses contained 62,932,794 daily milk yield records on 199,104 primiparous cows. Genetic correlations (rg) between recent and earlier daughter groups were 1 for both resilience indicators, which suggests that selection will result in changes in the phenotype in the next generation. Furthermore, low variance was genetically correlated with weak response in milk yield to both the heat wave and herd disturbances (rg 0.47 to 0.97). Low autocorrelation was genetically correlated with reduced perturbation length and quick recovery after the heat wave and herd disturbances (0.28 to 0.97). These results suggest that variance and autocorrelation cover different aspects of resilience, and should be combined in a resilience index. In conclusion, genetic selection for the resilience indicators will likely result in favorable changes in the traits themselves, and in response and recovery to actual disturbances, which confirms that they are useful resilience indicators.


Asunto(s)
Calor , Lactancia , Animales , Bovinos/genética , Femenino , Leche , Núcleo Familiar , Fenotipo
5.
Front Allergy ; 2: 761388, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-35386961

RESUMEN

Background: European patients with chronic rhinosinusitis with nasal polyps (CRSwNP) have had only limited occasions to unite to have their voices heard, hence missing the opportunity to contribute to the improvement of CRSwNP care. Aims: To identify unmet needs in CRSwNP from the perspective of CRSwNP patients from the Patient Advisory Board (PAB) of the European Forum for Research and Education in Allergy and Airways diseases (EUFOREA). Methodology: Semi-structured interviews were conducted individually with 15 European patients with CRSwNP and with a disease history of more than 2 years. Patients shared their burden of the disease and frustrations related to CRSwNP care, experiences with key pillars of current treatment options, shortcomings of the current care pathways and recommendations for improvement of care. A panel of 30 members of the Patient Advisory Board reviewed the interview report and provided further input during 2 virtual meetings. Results: CRSwNP patients indicated the need for greater awareness from society and physicians of the disease burden with impact on social function and well-being. Along with a loss of ability to smell and the continuous presence of secretions in the nose, most patients reported poor sleep quality and psychological impact as the most bothersome symptoms. Patients' frustrations relate primarily to the underestimation of the disease burden, the lack of coordination of care and the limited treatment options available to them. Treatment options with oral corticosteroids and/or sinus surgery both have positive and negative aspects, including the lack of long-lasting efficacy. Better coordination of care, more patient-centered care, greater public awareness, increases in research on the disease mechanisms and better therapeutic options would be warmly welcomed by CRSwNP patients. Conclusions: This statement of the EUFOREA Patient Advisory Board on CRSwNP provides novel insights on the underestimation of the burden of CRSwNP and shortcomings of current care. Multiple recommendations made by the patients can underpin action plans for implementation of better care for CRSwNP among all physicians treating patients with this disabling disease.

7.
J Dairy Sci ; 104(1): 616-627, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33272577

RESUMEN

Resilient cows are minimally affected in their functioning by infections and other disturbances, and recover quickly. Herd management is expected to have an effect on disturbances and the resilience of cows, and this effect was investigated in this study. Two resilience indicators were first recorded on individual cows. The effect of herd-year on these resilience indicators was then estimated and corrected for genetic and year-season effects. The 2 resilience indicators were the variance and the lag-1 autocorrelation of daily milk yield deviations from an expected lactation curve. Low variance and autocorrelation indicate that a cow does not fluctuate much around her expected milk yield and is, thus, subject to few disturbances, or little affected by disturbances (resilient). The herd-year estimates of the resilience indicators were estimated for 9,917 herd-year classes based on records of 227,655 primiparous cows from 2,644 herds. The herd-year estimates of the resilience indicators were then related to herd performance variables. Large differences in the herd-year estimates of the 2 resilience indicators (variance and autocorrelation) were observed between herd-years, indicating an effect of management on these traits. Furthermore, herd-year classes with a high variance tended to have a high proportion of cows with a rumen acidosis indication (r = 0.31), high SCS (r = 0.19), low fat content (r = -0.18), long calving interval (r = 0.14), low survival to second lactation (r = -0.13), large herd size (r = 0.12), low lactose content (r = -0.12), and high production (r = 0.10). These correlations support that herds with high variance are not resilient. The correlation between the variance and the proportion of cows with a rumen acidosis indication suggests that feed management may have an important effect on the variance. Herd-year classes with a high autocorrelation tended to have a high proportion of cows with a ketosis indication (r = 0.14) and a high production (r = 0.13), but a low somatic cell score (r = -0.17) and a low proportion of cows with a rumen acidosis indication (r = -0.12). These correlations suggest that high autocorrelation at herd level indicates either good or poor resilience, and is thus a poor resilience indicator. However, the combination of a high variance and a high autocorrelation is expected to indicate many fluctuations with slow recovery. In conclusion, herd management, in particular feed management, seems to affect herd resilience.


Asunto(s)
Variación Biológica Poblacional , Bovinos/genética , Industria Lechera , Lactancia/genética , Acidosis/metabolismo , Acidosis/veterinaria , Animales , Bovinos/fisiología , Enfermedades de los Bovinos/metabolismo , Femenino , Leche , Fenotipo , Rumen/metabolismo , Estaciones del Año
8.
J Dairy Sci ; 104(2): 1967-1981, 2021 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-33309360

RESUMEN

Resilience is the ability of cows to cope with disturbances, such as pathogens or heat waves. To breed for improved resilience, it is important to know whether resilience genetically changes throughout life. Therefore, the aim was to perform a genetic analysis on 2 resilience indicators based on data from 3 periods of the first lactation (d 11-110, 111-210, and 211-340) and the first 3 full lactations, and to estimate genetic correlations with health traits. The resilience indicators were the natural log-transformed variance (LnVar) and lag-1 autocorrelation (rauto) of daily deviations in milk yield from an expected lactation curve. Low LnVar and rauto indicate low variability in daily milk yield and quick recovery, and were expected to indicate good resilience. Data of 200,084 first, 155,784 second, and 89,990 third lactations were used. Heritabilities were similar based on different lactation periods (0.12-0.15 for LnVar, 0.05-0.06 for rauto). However, the heritabilities of the resilience indicators based on full first lactation were higher than those based on lactation periods (0.20 for LnVar, 0.08 for rauto), due to lower residual variances. Heritabilities decreased from 0.20 in full lactation 1 to 0.19 in full lactation 3 for LnVar and from 0.08 to 0.06 for rauto. For LnVar, as well as for rauto, the strongest genetic correlation between lactation periods was between period 2 and 3 (0.97 for LnVar, 0.96 for rauto) and the weakest between period 1 and 3 (0.81 for LnVar, 0.65 for rauto). Similarly, for both traits the genetic correlation between full lactations was strongest between lactations 2 and 3 (0.99 for LnVar, 0.95 for rauto) and weakest between lactations 1 and 3 (0.91 for LnVar, 0.71 for rauto). For LnVar, genetic correlations with resilience-related traits, such as udder health, ketosis, and longevity, adjusted for correlations with milk yield, were almost always favorable (-0.59 to 0.02). In most cases these genetic correlations were stronger based on full lactations than on lactation periods. Genetic correlations were similar across full lactations, but the correlation with udder health increased substantially from -0.31 in lactation 1 to -0.51 in lactation 3. For rauto, genetic correlations with resilience-related traits were always favorable in lactation period 1 and in most full lactations, but not in the other lactation periods. However, correlations were weak (-0.27 to 0.15). Therefore, as a resilience indicator for breeding, LnVar is preferred over rauto. A multitrait index based on estimated breeding values for LnVar in lactations 1, 2, and 3 is recommended to improve resilience throughout the lifetime of a cow.


Asunto(s)
Bovinos/genética , Lactancia/genética , Leche/metabolismo , Animales , Bovinos/fisiología , Femenino , Pruebas Genéticas/veterinaria , Longevidad , Glándulas Mamarias Animales/fisiología , Fenotipo
9.
J Dairy Sci ; 103(2): 1667-1684, 2020 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-31759590

RESUMEN

The ability of a cow to cope with environmental disturbances, such as pathogens or heat waves, is called resilience. To improve resilience through breeding, we need resilience indicators, which could be based on the fluctuation patterns in milk yield resulting from disturbances. The aim of this study was to explore 3 traits that describe fluctuations in milk yield as indicators for breeding resilient cows: the variance, autocorrelation, and skewness of the deviations from individual lactation curves. We used daily milk yield records of 198,754 first-parity cows, recorded by automatic milking systems. First, we estimated a lactation curve for each cow using 4 different methods: moving average, moving median, quantile regression, and Wilmink curve. We then calculated the log-transformed variance (LnVar), lag-1 autocorrelation (rauto), and skewness (Skew) of the daily deviations from these curves as resilience indicators. A genetic analysis of the resilience indicators was performed, and genetic correlations between resilience indicators and health, longevity, fertility, metabolic, and production traits were estimated. The heritabilities differed between LnVar (0.20 to 0.24), rauto (0.08 to 0.10), and Skew (0.01 to 0.02), and the genetic correlations among the indicators were weak to moderate. For rauto and Skew, genetic correlations with health, longevity, fertility, and metabolic traits were weak or the opposite of what we expected. Therefore, rauto and Skew have limited value as resilience indicators. However, lower LnVar was genetically associated with better udder health (genetic correlations from -0.22 to -0.32), better longevity (-0.28 to -0.34), less ketosis (-0.27 to -0.33), better fertility (-0.06 to -0.17), higher BCS (-0.29 to -0.40), and greater dry matter intake (-0.53 to -0.66) at the same level of milk yield. These correlations support LnVar as an indicator of resilience. Of all 4 curve-fitting methods, LnVar based on quantile regression systematically had the strongest genetic correlations with health, longevity, and fertility traits. Thus, quantile regression is considered the best curve-fitting method. In conclusion, LnVar based on deviations from a quantile regression curve is a promising resilience indicator that can be used to breed cows that are better at coping with disturbances.


Asunto(s)
Adaptación Fisiológica , Cruzamiento , Bovinos , Lactancia , Animales , Bovinos/genética , Femenino , Fertilidad/genética , Lactancia/genética , Longevidad , Leche , Fenotipo , Embarazo
10.
Resuscitation ; 142: 61-68, 2019 09.
Artículo en Inglés | MEDLINE | ID: mdl-31326405

RESUMEN

AIM: Whether time of day influences survival after out-of-hospital cardiac arrest (OHCA) remains controversial. We compared outcomes after OHCA between day and night and explored whether characteristics of pre-hospital advanced life support (ALS)-quality varied by time of day. METHODS: We conducted a prospective cohort study of individuals that suffered a non-traumatic OHCA in the city of Vienna between August 2013 and August 2015 and who received resuscitative efforts by EMS. We compared clinical outcomes between day and night, defined as 7:00 pm-7:00 am based on EMS shift time including rates of sustained return of spontaneous circulation (ROSC), 30-day survival and favourable neurologic outcome (cerebral performance category 1 or 2). ALS quality measures included time to first medical contact, time to first shock, total dose of epinephrine, and multiple ALS performance measures. RESULTS: We included 1811 patients (37% female) with a mean age of 67 ± 16 years in our analyses. Rates of ROSC and 30-day survival with favourable neurological outcome did not differ between day or night (30% vs 28%, p =  0.33; 12% vs. 11%, p =  0.51, respectively). These results remained unchanged after multivariate adjustment for ROSC (RR, 1.1; 95% CI, 1.0-1.3, p = 0.19) and 30-day survival with favourable neurological outcome (RR, 1.2; 95% CI, 1.0-1.5, p =  0.10). The quality of ALS did not differ between day and night. CONCLUSIONS: In contrast to previous studies, there was no significant difference in sustained ROSC rates and 30-day survival with favourable neurological outcome after OHCA between day and night in the city of Vienna. This is likely due to nearly identical high bystander CPR rates and identical ALS performance provided by EMS personnel irrespective of time of the day.


Asunto(s)
Apoyo Vital Cardíaco Avanzado , Servicios Médicos de Urgencia , Paro Cardíaco Extrahospitalario , Tiempo de Tratamiento/estadística & datos numéricos , Apoyo Vital Cardíaco Avanzado/métodos , Apoyo Vital Cardíaco Avanzado/normas , Apoyo Vital Cardíaco Avanzado/estadística & datos numéricos , Anciano , Austria/epidemiología , Estudios de Cohortes , Servicios Médicos de Urgencia/métodos , Servicios Médicos de Urgencia/normas , Servicios Médicos de Urgencia/estadística & datos numéricos , Femenino , Humanos , Masculino , Paro Cardíaco Extrahospitalario/mortalidad , Paro Cardíaco Extrahospitalario/terapia , Evaluación de Procesos y Resultados en Atención de Salud , Estudios Prospectivos , Análisis de Supervivencia
11.
J Dairy Sci ; 102(2): 1386-1396, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30617003

RESUMEN

Cartesian teat coordinates measured by automatic milking systems (AMS) provide new opportunities to record udder conformation traits and to study changes in udder conformation genetically and phenotypically within and between parities. The objective of this study was to estimate heritabilities and repeatabilities of AMS-based udder conformation traits within parities, to estimate genetic correlations between parities for AMS-based udder conformation traits, and to estimate genetic correlations between AMS-based udder conformation traits and classifier-based udder conformation traits, longevity, and udder health. Data from 70 herds, including 12,663 first-parity cows, 10,206 second-parity cows, and 7,627 third-parity cows, were analyzed using univariate and bivariate mixed animal models. Heritabilities of the AMS udder conformation traits were large (0.37-0.67) and genetic correlations between the AMS udder conformation traits and classifier-based traits were strong (>0.91). Repeatabilities within parities were large as well (0.89-0.97), indicating that a single record on udder conformation per lactation reflects udder conformation well. Genetic correlations of AMS udder conformation traits between parities were strong (0.88-1.00) and were stronger than the permanent environmental correlations. This shows that udder conformation changes over parities, but this change is mostly due to nongenetic factors. Based on these results, the current herd classification system, where cows are scored on udder conformation once in first parity, is sufficient. The AMS udder conformation traits as defined in this study have limited value as replacement for classifier-based udder conformation traits because they have smaller genetic correlations with functional traits than classifier-based traits. In summary, udder conformation hardly changes genetically between parities and is highly repeatable within parities. Udder conformation traits based on AMS need fine-tuning before they can replace classifier-based traits, and AMS teat coordinates probably contain additional information about udder health that is yet to be explored.


Asunto(s)
Bovinos/genética , Industria Lechera/métodos , Glándulas Mamarias Animales/anatomía & histología , Animales , Femenino , Genotipo , Lactancia , Longevidad , Leche , Paridad , Fenotipo , Embarazo , Carácter Cuantitativo Heredable , Registros/veterinaria , Reproducibilidad de los Resultados
12.
Environ Manage ; 61(1): 69-84, 2018 01.
Artículo en Inglés | MEDLINE | ID: mdl-29150720

RESUMEN

The Morphological Quality Index (MQI) and the Morphological Quality Index for monitoring (MQIm) have been applied to eight case studies across Europe with the objective of analyzing the hydromorphological response to various restoration measures and of comparing the results of the MQI and MQIm as a morphological assessment applied at the reach scale, with a conventional site scale physical-habitat assessment method. For each restored reach, the two indices were applied to the pre-restoration and post-restoration conditions. The restored reach was also compared to an adjacent, degraded reach. Results show that in all cases the restoration measures improved the morphological quality of the reach, but that the degree of improvement depends on many factors, including the initial morphological conditions, the length of the restored portion in relation to the reach length, and on the type of intervention. The comparison with a conventional site scale physical-habitat assessment method shows that the MQI and MQIm are best suited for the evaluation of restoration effects on river hydromorphology at the geomorphologically-relevant scale of the river reach.


Asunto(s)
Conservación de los Recursos Naturales , Monitoreo del Ambiente , Ríos/química , Ecosistema , Europa (Continente)
13.
Health Technol Assess ; 17(7): 1-166, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23438937

RESUMEN

OBJECTIVE: Depression is common in dementia, causing considerable distress and other negative impacts. Treating it is a clinical priority, but the evidence base is sparse and equivocal. This trial aimed to determine clinical effectiveness of sertraline and mirtazapine in reducing depression 13 weeks post randomisation compared with placebo. DESIGN: Multicentre, parallel-group, double-blind placebo-controlled randomised controlled trial of the clinical effectiveness of sertraline and mirtazapine with 13- and 39-week follow-up. SETTING: Nine English old-age psychiatry services. PARTICIPANTS: A pragmatic trial. Eligibility: probable or possible Alzheimer's disease (AD), depression (4+ weeks) and Cornell Scale for Depression in Dementia (CSDD) score of 8+. EXCLUSIONS: clinically too critical (e.g. suicide risk); contraindication to medication; taking antidepressants; in another trial; and having no carer. INTERVENTIONS: (1) Sertraline; (2) mirtazapine; and (3) placebo, all with normal care. Target doses: 150 mg of sertraline or 45 mg of mirtazapine daily. OUTCOME: CSDD score. Randomisation: Allocated 1 : 1 : 1 through Trials Unit, independently of trial team. Stratified block randomisation by centre, with randomly varying block sizes; computer-generated randomisation. Blinding: Double blind: medication and placebo identical for each antidepressant. Referring clinicians, research workers, participants and pharmacies were blind. Statisticians blind until analyses completed. RESULTS: Numbers randomised: 326 participants randomised (111 placebo, 107 sertraline and 108 mirtazapine). OUTCOME: Differences in CSDD at 13 weeks from an adjusted linear-mixed model: mean difference (95% CI) placebo-sertraline 1.17 (-0.23 to 2.78; p = 0.102); placebo-mirtazapine 0.01 (-1.37 to 1.38; p = 0.991); and mirtazapine-sertraline 1.16 (-0.27 to 2.60; p = 0.112). HARMS: Placebo group had fewer adverse reactions (29/111, 26%) than sertraline (46/107, 43%) or mirtazapine (44/108, 41%; p = 0.017); 39-week mortality equal, five deaths in each group. CONCLUSIONS: This is a trial with negative findings but important clinical implications. The data suggest that the antidepressants tested, given with normal care, are not clinically effective (compared with placebo) for clinically significant depression in AD. This implies a need to change current practice of antidepressants being the first-line treatment of depression in AD. From the data generated we formulated the following recommendations for future work. (1) The secondary analyses presented here suggest that there would be value in carrying out a placebo-controlled trial of the clinical effectiveness and cost-effectiveness of mirtazapine in the management of Behavioural and Psychological Symptoms of Dementia. (2) A conclusion from this study is that it remains both ethical and essential for trials of new medication for depression in dementia to have a placebo arm. (3) Further research is required to evaluate the impact that treatments for depression in people with dementia can have on their carers not only in terms of any impacts on their quality of life, but also the time they spend care-giving. (4) There is a need for research into alternative biological and psychological therapies for depression in dementia. These could include evaluations of new classes of antidepressants (such as venlafaxine) or antidementia medication (e.g. cholinesterase inhibitors). (5) Research is needed to investigate the natural history of depression in dementia in the community when patients are not referred to secondary care services. (6) Further work is needed to investigate the cost modelling results in this rich data set, investigating carer burden and possible moderators to the treatment effects. (7) There is scope for reanalysis of the primary outcome in terms of carer and participant CSDD results.


Asunto(s)
Antidepresivos Tricíclicos/uso terapéutico , Antidepresivos/uso terapéutico , Demencia/psicología , Depresión/tratamiento farmacológico , Mianserina/análogos & derivados , Sertralina/uso terapéutico , Anciano , Análisis Costo-Beneficio , Demencia/complicaciones , Depresión/etiología , Método Doble Ciego , Femenino , Humanos , Masculino , Mianserina/uso terapéutico , Mirtazapina , Pruebas Neuropsicológicas , Escalas de Valoración Psiquiátrica , Calidad de Vida/psicología , Encuestas y Cuestionarios , Resultado del Tratamiento
14.
J Neurol Neurosurg Psychiatry ; 78(3): 233-9, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17012333

RESUMEN

BACKGROUND: Prescribed drugs in patients with Alzheimer's disease may affect the symptomatic progression of their disease, both positively and negatively. AIM: To examine the effects of drugs on the progression of disease in a representative group of patients with Alzheimer's disease. METHODS: Patients with the diagnosis of probable Alzheimer's disease were recruited from the community. The prescribed drugs taken by 224 patients (mean age 82.3 years) were recorded at initial assessment and then correlated in logistic regression analysis with progression of the disease, defined as an increase of one point or more in the Global Deterioration Scale over the next 12-month period. RESULTS: Patients who were taking antipsychotic drugs and sedatives had a significantly higher risk of deterioration than those who were taking none (odds ratios (ORs) 2.74 (95% confidence interval (CI) 1.17 to 6.41) and 2.77 (95% CI 1.14 to 6.73), respectively). Higher risk of deterioration was observed in those who were taking both antipsychotic and sedative drugs together (OR 3.86 (95% CI 1.28 to 11.7). Patients taking drugs licensed for dementia, drugs affecting the renin-angiotensin system and statins had a significantly lower risk of deterioration than those who were not taking any of these drugs (ORs 0.49 (95% CI 0.25 to 0.97), 0.31 (95% CI 0.11 to 0.85) and 0.12 (95% CI 0.03 to 0.52), respectively). CONCLUSION: Our findings have implications for both clinicians and trialists. Most importantly, clinicians should carefully weigh any potential benefits of antipsychotics and benzodiazepines, especially in combination, against the risk of increased decline. Researchers need to be aware of the potential of not only licensed drugs for dementia but also drugs affecting the renin-angiotensin system and statins in reducing progression in clinical trials.


Asunto(s)
Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/patología , Antipsicóticos/efectos adversos , Prescripciones de Medicamentos , Hipnóticos y Sedantes/efectos adversos , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/tratamiento farmacológico , Antidepresivos/efectos adversos , Antidepresivos/uso terapéutico , Antioxidantes/efectos adversos , Antioxidantes/uso terapéutico , Antipsicóticos/uso terapéutico , Estudios de Cohortes , Progresión de la Enfermedad , Femenino , Humanos , Hipnóticos y Sedantes/uso terapéutico , Masculino , Sistema Renina-Angiotensina/efectos de los fármacos , Factores de Riesgo
15.
Oncogene ; 26(24): 3462-72, 2007 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-17160020

RESUMEN

Helicobacter pylori induces a strong motogenic response in infected gastric epithelial host cells, which is enhanced by translocation of the pathogenic factor cytotoxin-associated gene A (CagA) into host cells via a specialized type IV secretion system. Once injected into the cytosol CagA is rapidly tyrosine phosphorylated by Src family kinases followed by Src inactivation. Hence, it remained unknown why CagA is constantly phosphorylated in sustained H. pylori infections to induce cell migration, whereas other substrates of Src kinases are dephosphorylated. Here, we identify the non-receptor tyrosine kinase c-Abl as a crucial mediator of H. pylori-induced migration and novel CagA kinase in epithelial cells. Upon H. pylori infection c-Abl directly interacts with CagA and localizes in focal adhesion complexes and membrane ruffles, which are highly dynamic cytoskeletal structures necessary for cell motility. Selective inhibition of c-Abl kinase activity by STI571 or shRNA abrogates sustained CagA phosphorylation and epithelial cell migration, indicating a pivotal role of c-Abl in H. pylori infection and pathogenicity. These results implicate c-Abl as a novel molecular target for therapeutic intervention in H. pylori-related gastric diseases.


Asunto(s)
Antígenos Bacterianos/metabolismo , Proteínas Bacterianas/metabolismo , Movimiento Celular , Infecciones por Helicobacter/metabolismo , Infecciones por Helicobacter/patología , Proteínas Proto-Oncogénicas c-abl/metabolismo , Antígenos Bacterianos/genética , Proteínas Bacterianas/genética , Benzamidas , Adhesión Celular , Línea Celular Tumoral , Células Epiteliales/patología , Helicobacter pylori/patogenicidad , Humanos , Mesilato de Imatinib , Fosforilación , Piperazinas/farmacología , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Proto-Oncogénicas c-abl/antagonistas & inhibidores , Proteínas Proto-Oncogénicas c-abl/genética , Pirimidinas/farmacología
16.
Brain ; 129(Pt 11): 3042-50, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17071923

RESUMEN

Alzheimer's disease is a common and devastating disease for which there is no readily available biomarker to aid diagnosis or to monitor disease progression. Biomarkers have been sought in CSF but no previous study has used two-dimensional gel electrophoresis coupled with mass spectrometry to seek biomarkers in peripheral tissue. We performed a case-control study of plasma using this proteomics approach to identify proteins that differ in the disease state relative to aged controls. For discovery-phase proteomics analysis, 50 people with Alzheimer's dementia were recruited through secondary services and 50 normal elderly controls through primary care. For validation purposes a total of 511 subjects with Alzheimer's disease and other neurodegenerative diseases and normal elderly controls were examined. Image analysis of the protein distribution of the gels alone identifies disease cases with 56% sensitivity and 80% specificity. Mass spectrometric analysis of the changes observed in two-dimensional electrophoresis identified a number of proteins previously implicated in the disease pathology, including complement factor H (CFH) precursor and alpha-2-macroglobulin (alpha-2M). Using semi-quantitative immunoblotting, the elevation of CFH and alpha-2M was shown to be specific for Alzheimer's disease and to correlate with disease severity although alternative assays would be necessary to improve sensitivity and specificity. These findings suggest that blood may be a rich source for biomarkers of Alzheimer's disease and that CFH, together with other proteins such as alpha-2M may be a specific markers of this illness.


Asunto(s)
Enfermedad de Alzheimer/diagnóstico , Proteínas Sanguíneas/análisis , Proteoma , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Estudios de Casos y Controles , Factor H de Complemento/análisis , Diagnóstico Diferencial , Electroforesis en Gel Bidimensional/métodos , Femenino , Humanos , Masculino , Enfermedades Neurodegenerativas/diagnóstico , Proteómica/métodos , Sensibilidad y Especificidad , alfa-Macroglobulinas/análisis
17.
J Biomed Mater Res B Appl Biomater ; 71(1): 130-43, 2004 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-15368237

RESUMEN

In this study, the proliferation and differentiation of rat calvarial osteoblasts cultured on either (1) calcium-phosphate bone cement Biocement D, (2) Biocement D with 2.5% (w/w) mineralized collagen type I, or (3) Biocement D with 2.5% (w/w) mineralized collagen type I and 3% (w/w) citric acid were investigated. Incubation of the composites in cell-culture medium resulted in a fast decrease of pH and calcium concentration as well as in an increase of phosphate concentration. Although these effects occurred with all investigated materials, the lowest extent could be observed for the citric-acid-containing composites. As shown by scanning-electron microscopy, osteoblasts adhered to the composite surfaces. Proliferation and differentiation of the cells grown on the composites were found to be reduced compared to cells grown on tissue-culture polystyrene. Cells cultured in the vicinity of the composites but without direct contact also exhibited a reduced rate of proliferation, reduced alkaline phosphatase activity, and reduced mineralization. Simulating the changes in calcium and phosphate concentration occasioned by the composites through exposing cells to EGTA and phosphate gives rise to the same effects of reducing proliferation, ALP activity, and mineralization. No indication for apoptosis in cells exposed to low calcium and high phosphate concentrations was found. The number of necrotic cells, however, increased after incubation with EGTA and phosphate. For assessment of cell-composite interactions and the success of the composites in vivo, as well as for more effective material development, it seems to be important to know how changes in microenvironmental pH and ion composition of the material affect cellular proliferation and differentiation.


Asunto(s)
Cementos para Huesos/farmacología , Ácido Cítrico/farmacología , Colágeno Tipo I/farmacología , Osteoblastos/química , Animales , Fosfatos de Calcio , Diferenciación Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Ensayo de Materiales , Microscopía Electrónica de Rastreo , Compuestos Orgánicos , Osteoblastos/efectos de los fármacos , Osteoblastos/ultraestructura , Ratas
18.
Neuropediatrics ; 35(2): 139-42, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15127315

RESUMEN

Familial incontinentia pigmenti (IP) (OMIM #308300) is a rare genetic disorder which segregates in an X-linked dominant way. The female-to-male ratio ranges from 20 to 37 : 1. In affected females IP causes highly variable abnormalities of the skin, hair, nails, teeth, eyes, and central nervous system (CNS). Cardiovascular anomalies, cerebral infarction, and immune dysfunction are rare complications of IP. The pathogenesis of cerebral changes in IP remains elusive. We report the case of two IP-affected sisters who presented in each case with neonatal seizures on the fifth day of life. Via cranial magnetic resonance tomographic imaging (MRI) different types of lesions in both hemispheres were demonstrable in both patients. To date the pathogenetic mechanisms for the cerebral lesions are not fully understood. However, multiple microscopic infarcts could serve as a possible explanation. The clinical course and the neurological development of the older child are favorable and so far the younger sibling appears to be developing normally, which is uncommon for patients with early onset of neurological symptoms. Symptomatic seizures in IP are an important differential diagnosis in benign non-familial and familial neonatal seizures.


Asunto(s)
Incontinencia Pigmentaria/genética , Convulsiones/congénito , Encéfalo/patología , Encéfalo/fisiopatología , Femenino , Humanos , Incontinencia Pigmentaria/patología , Recién Nacido , Linaje , Convulsiones/patología , Hermanos
19.
Neuropediatrics ; 34(3): 113-9, 2003 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12910433

RESUMEN

Kleine-Levin syndrome (KLS) is a rare disorder which affects mainly adolescents. Periods of extreme somnolence alternate with megaphagia, psychomental changes and behavioural symptoms. The cause and pathogenesis of KLS remains unknown. Several treatments have been tried and recently lithium has been proposed for a prophylactic use in single cases. In view of the rarity of KLS, long-term results of lithium therapy have not been described yet. We report the clinical course of five adolescents with KLS who were treated with lithium. All patients showed significant EEG and polysomnographic changes during the episodes and had normal results in the interval. All patients had relapses while being treated with lithium. But episodes of hypersomnia under lithium therapy were shorter and monosymptomatic with lack of behavioural symptoms. Statistical modelling showed that the risk for a relapsing episode under maintenance of lithium drops per months of therapy from 100 % to 93 %, and furthermore that the maintenance of lithium shortens the mean duration of episodes to 19 %. No severe side effects were observed. In conclusion, in KLS with a high frequency of episodes and severe behavioural changes lithium may become a treatment option.


Asunto(s)
Antipsicóticos/uso terapéutico , Síndrome de Kleine-Levin/tratamiento farmacológico , Carbonato de Litio/uso terapéutico , Adolescente , Trastornos de Somnolencia Excesiva/diagnóstico , Electroencefalografía , Femenino , Humanos , Síndrome de Kleine-Levin/diagnóstico , Masculino , Polisomnografía , Fases del Sueño/fisiología
20.
Neurology ; 60(8): 1246-51, 2003 Apr 22.
Artículo en Inglés | MEDLINE | ID: mdl-12707425

RESUMEN

BACKGROUND: Mutations in the fukutin-related protein gene FKRP cause limb-girdle muscular dystrophy (LGMD2I) as well as a form of congenital muscular dystrophy (MDC1C). OBJECTIVE: To define the phenotype in LGMD2I. METHODS: The authors assessed 16 patients from 14 families with FKRP gene mutations and LGMD and collected the results of mutation analysis, protein studies, and respiratory and cardiac investigations. RESULTS: Thirteen patients, most with adult presentation, were homozygous for the common C826A mutation in FKRP. The three other cases were compound heterozygotes for C826A and two of them presented in childhood, with more progressive disease. The pattern of muscle involvement, frequently including calf hypertrophy, was similar to dystrophinopathy. Complications in patients with LGMD2I were common and sometimes out of proportion to the skeletal muscle involvement. Six patients had cardiac involvement, and 10 had respiratory impairment: five required nocturnal respiratory support. All patients had serum creatine kinase at least 5 to 70 times normal. The most consistent protein abnormality found on muscle biopsy was a reduction of laminin alpha2 immunolabeling, either on muscle sections or immunoblotting alone. CONCLUSIONS: LGMD2I due to FKRP mutations appears to be a relatively common cause of LGMD, with respiratory and cardiac failure as prominent complications.


Asunto(s)
Distrofias Musculares/genética , Proteínas/genética , Adolescente , Adulto , Sustitución de Aminoácidos , Niño , Análisis Mutacional de ADN , Progresión de la Enfermedad , Femenino , Genotipo , Insuficiencia Cardíaca/etiología , Humanos , Laminina/deficiencia , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Músculo Esquelético/química , Músculo Esquelético/patología , Distrofias Musculares/clasificación , Distrofias Musculares/complicaciones , Distrofias Musculares/patología , Mutación Missense , Pentosiltransferasa , Fenotipo , Mutación Puntual , Insuficiencia Respiratoria/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...